middle.news
Nyrada funds Xolatryp’s next clinical test with AU$12 million placement
9:31am on Monday 21st of September, 2026 AEST
•
Biotechnology
Read Story
Nyrada funds Xolatryp’s next clinical test with AU$12 million placement
9:31am on Monday 21st of September, 2026 AEST
Key Points
AU$12.0 million placement at AU$0.62 per CDI
Further non-underwritten SPP targeting up to AU$2.0 million
Directors propose subscribing for AU$5.125 million, subject to approval
Funds expected to support PROTECT-MI through topline data
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Nyrada (ASX:NYR)
OPEN ARTICLE